In Nov. 2022, the U.S. nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) announced that it had concluded a second stage-3 demo on MDMA as being a treatment method for PTSD—a action greatly https://jasonemeb061496.wikijournalist.com/user